Clinical Trials Browser

Phase NA × Cytomegalovirus Infections × Valganciclovir × Clear all

NCT07294547 2025-12-19

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Phase NA Recruiting

Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT00400322 2021-03-01

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Phase NA Completed

Cytomegalovirus Infections, Glioblastoma